Qualia Clinical Research Services

Qualia Clinical Research Services was a contract research organization (CRO) that specialized in early-phase clinical research and Phase I clinical trials. Based in Omaha, Nebraska, the company operated a significant clinical pharmacology unit with a capacity of up to 160 beds, designed to conduct complex pharmacokinetic, pharmacodynamic, and bioequivalence studies. The firm provided comprehensive services to pharmaceutical and biotechnology clients, including study design, volunteer recruitment, and clinical conduct for first-in-human trials. In 2009, the company's assets were acquired by ICON plc, a leading global provider of drug development services, to strengthen ICON's early-stage clinical research capabilities in North America.